Medical Management of Cerebral Vasospasm - PowerPoint PPT Presentation

1 / 17
About This Presentation
Title:

Medical Management of Cerebral Vasospasm

Description:

S.A.H. Medical Management of Cerebral Vasospasm Mark Angle, M.D. MNH / I-2001 Cerebral Vasospasm: A Syndrome of Delayed Regional Hypoperfusion Post Sub-Arachnoid ... – PowerPoint PPT presentation

Number of Views:246
Avg rating:3.0/5.0
Slides: 18
Provided by: MUHC7
Category:

less

Transcript and Presenter's Notes

Title: Medical Management of Cerebral Vasospasm


1
Medical Management of Cerebral Vasospasm
S.A.H.
  • Mark Angle, M.D.
  • MNH / I-2001

2
Cerebral Vasospasm
S.A.H.
  • A Syndrome of Delayed Regional Hypoperfusion Post
    Sub-Arachnoid Hemorrhage

3
Delayed Ischemic Neurological Deficits ? Onset
4 - 14 days post - SAH ? Focal or global ?
Differential diagnosis 1. Hydrocephalus 2.
Re-hemorrhage 3. Hyponatremia 4. Concurrent
illness 5. Seizure(s) 6. Vasospasm
S.A.H.
4
Pathophysiologyof Vasospasm
S.A.H.
Clot-Derived Oxyhemoglobin
  • Local InflammatoryArteritis
  • Local / Distal
  • Vasoconstricition

5
VasomotorDysregulation
S.A.H.
  • Early Enhanced Calcium Entry into
  • Smooth Muscle
  • Late Activation of PKC

6
S.A.H.
  • Vasospasm
  • Modulators
  • NO ? cGMP
  • Endothelin ? PKC
  • Eicosonoids ? cAMP, IP 3

7
Cortical Necrosis
S.A.H.
  • Critical Hypoperfusion
  • Paradoxical Micro vascular Constriction after
    Cortical
  • Activation

8
Predictors of Vasospasm
S.A.H.
  • Thickness of Clot (Fischer)
  • Hydrocephalus
  • Prior Smoking History
  • Prior Hypertension
  • (Early Surgical Intervention)
  • Intra-Operative Hypotension

9
Treatment of Vasospasm
S.A.H.
  • Prophylaxis
  • Risk Management
  • Baro-Therapy
  • Vaso-Therapy

10
Diagnosis of Vasospasm
S.A.H.
  • Symptoms (Delayed Neurological Deficits)
  • Angiography DS vs CTA
  • TCD
  • Perfusion Xe CT, CT perfusion
  • Tissue Monitoring
  • Spectroscopy
  • Microdialysis

11
Vasospasm A Systemic Illness?
S.A.H.
  • Systemic Inflammatory Response (leukocytosis,
    tachycardia, tachypnea, fever)
  • Natriuresis
  • Fever

12
Vasospasm Prophylaxis
S.A.H.
  • Cisternal Drainage
  • Immunotherapy
  • (steroids)
  • Experimental Pharmacotherapy

13
Vasospasm Risk Management
S.A.H.
  • Nimodipine
  • Triple H

14
Triple - H
S.A.H.
  • Hemodilution
  • ? hct 30 - 32
  • Hypervolemia
  • ? CVP 10 - 12
  • Hypertension
  • ? ? MAP 20 - 40

15
Symptomatic Vasospasm
S.A.H.
  • Results of Best Practice
  • CVA at 24 hrs. - 40 - 50
  • Poor Outcome - 40 - 50

16
Milrinone Actions
S.A.H.
  • PDE III Inhibitor
  • ? ? cAMP
  • ? ? cGMP
  • Immuno Modulator
  • ? ? TNF, IL-6
  • ? ? Platelet Adhesion
  • ? ? wbc chemopexis
  • Cardiac Inotrope

17
Vasospasm Treatment Protocol
S.A.H.
  • Optimal Medical Management
  • Euvolemia
  • Normo - Natremia
  • Milrinone Trial
  • Salvage Hypertension
  • Angioplasty
Write a Comment
User Comments (0)
About PowerShow.com